Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Reducing stroke recurrence through nurse-led education in Bangladesh

Official title: Effectiveness of Health Education Program Among Patients & Family Caregivers on Modifiable Risk Factors mRS 0 to 4 to Reduce Recurrence of Stroke After Discharge From a Tertiary Hospital in Bangladesh

Run by Hiroshima University · NCT05520034 · Data updated 2026-11-12

This study tests if education from nurses can help first-time stroke patients and their caregivers in Bangladesh make better lifestyle choices to prevent another stroke.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment432 (estimated)
SponsorHiroshima University
Academic / other
Locations1 site (Dhaka)
StatusRecruiting
StartedOctober 2, 2022
Main results expectedFebruary 28, 2024
Study endsMarch 30, 2026
Registry record updatedSeptember 15, 2025
Trial IDNCT05520034 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include first-time stroke patients aged 18 and older who have been discharged from the National Institute of Neurosciences & Hospital.

Probably not a fit

Patients with a history of recurrent strokes or those with specific stroke subtypes, such as subarachnoid hemorrhage, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of nurse-led health education for first-time stroke patients and their family caregivers in Bangladesh. The aim is to reduce the recurrence of stroke by improving knowledge and compliance with treatment regarding modifiable risk factors. Participants will receive education on lifestyle changes and self-monitoring techniques, while their health outcomes will be assessed over time. The study will also track adverse events and changes in health metrics such as cholesterol levels and blood pressure.

Why it matters

Potential benefit: If successful, this approach could significantly lower the rate of stroke recurrence among patients in Bangladesh.

How similar studies have gone: Other studies have shown that health education can effectively reduce recurrence rates in stroke patients, suggesting this approach has potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
For patient

1. Who was discharged from NINSH to home or who visited NINSH right after getting a stroke
2. First-time stroke
3. All types of strokes, except subarachnoid haemorrhage
4. modified Rankin Scale (0 - 4)
5. Stroke patient who is 18 years old and above
6. Both males \& females
7. Who provided written consent \& willing to participate in the study

For family caregivers

1. Primary caregivers irrespective of sex and aged 18 years old and above, living with the patient who take care of an above patient and who meets all of the inclusion criteria (will be decided by one person)
2. Who will provide written consent \& willing to participate in the study

Exclusion Criteria:

Exclusion criteria of patient

1. Who has stroke with the recurrence
2. Stroke subtype: caused by genetic problems or injury/accident
3. Patients with multi-organ failure or terminal stage
4. Participation in other clinical trials
5. Unwillingness to participate in the study
6. Not having a mobile phone at home
7. mRS 5

Exclusion criteria of caregiver

1. Who is not living with the patient
2. Who is under 18 years old
3. Who is mentally unstable and/or cognitively impaired (diagnosed cases)

Where it's running

  • National Institute of Neurosciences & Hospital
    Dhaka, Bangladesh
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.